Cardiovascular disease (CVD) is a significant cause of morbidity and mortality among patients with diabetes mellitus (DM). Increased platelet reactivity among patients with DM contributes to disproportionately high levels of atherothrombotic CVD. Consequently, there has been tremendous interest in exploring the role of antiplatelet therapies in DM to reduce the development of and frequency of future cardiovascular events.
Keywords: Antiplatelet therapy; Antithrombotic therapy; Cardiovascular disease; Diabetes; Thrombosis.
Copyright © 2017 Elsevier Inc. All rights reserved.